Ceritinib dihydrochloride (Standard)
Ceritinib dihydrochloride (Standard) is the analytical standard of Ceritinib dihydrochloride. This product is intended for research and analytical applications. Ceritinib dihydrochloride (LDK378 dihydrochloride) is a selective, orally bioavailable and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib dihydrochloride (LDK378 dihydrochloride) also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib dihydrochloride (LDK378 dihydrochloride) shows great antitumor potency[1][2].
Product Specifications
CAS Number
1380575-43-8
UNSPSC
12352100
Target
Anaplastic lymphoma kinase (ALK) ; IGF-1R; Insulin Receptor; Reference Standards
Related Pathways
Others; Protein Tyrosine Kinase/RTK
Field of Research
Cancer; Endocrinology
Smiles
CC(C)OC1=CC(C2CCNCC2)=C(C)C=C1NC3=NC=C(Cl)C(NC4=CC=CC=C4S(=O)(C(C)C)=O)=N3.[H]Cl.[H]Cl
Molecular Formula
C28H38Cl3N5O3S
Molecular Weight
631.06
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Histone H1 (AE-4), CF488A conjugate, 0.1mg/mL
CD35 / CR1 (CR1/802), CF568 conjugate, 0.1mg/mL
Von Willebrand Factor (3E2D10 + VWF635), CF647 conjugate, 0.1mg/mL
CD45 / LCA (136-4B5), CF740 conjugate, 0.1mg/mL
CD8A (Cytotoxic-&Suppressor T-Cell Marker) (rC8/468), CF640R conjugate, 0.1mg/mL
